Table of Content

1. Executive Summary
   1.1. Global Nuclear Medicine Market Snapshot, 2024 and 2031
   1.2. Market Opportunity Assessment, 2024 - 2031, US$ Bn
   1.3. Key Market Trends
   1.4. Future Market Projections
   1.5. Premium Market Insights
   1.6. Industry Developments and Key Market Events
   1.7. PMR Analysis and Recommendations

2. Market Overview
   2.1. Market Scope and Definition
   2.2. Market Dynamics
       2.2.1. Drivers
       2.2.2. Restraints
       2.2.3. Opportunity
       2.2.4. Challenges
       2.2.5. Key Trends
   2.3. Macro-Economic Factors
       2.3.1. Global Sectorial Outlook
       2.3.2. Global GDP Growth Outlook
       2.3.3. Global Healthcare Spending Outlook
   2.4. COVID-19 Impact Analysis
   2.5. Forecast Factors - Relevance and Impact

3. Value Added Insights
   3.1. Epidemiology - Disease Prevalence and Incidence
   3.2. Technology Assessment
   3.3. Regulatory Landscape
   3.4. Value Chain Analysis
   3.5. Key Deals and Mergers
   3.6. PESTLE Analysis
   3.7. Porter’s Five Force Analysis

4. Global Nuclear Medicine Market Outlook: Historical (2018 - 2023) and Forecast (2024 - 2031)
   4.1. Key Highlights
       4.1.1. Market Size (US$ Bn) and Y-o-Y Growth
       4.1.2. Absolute $ Opportunity
   4.2. Market Size (US$ Bn) Analysis and Forecast
       4.2.1. Historical Market Size (US$ Bn) Analysis, 2018-2022
       4.2.2. Current Market Size (US$ Bn) Analysis and Forecast, 2023-2031
   4.3. Global Nuclear Medicine Market Outlook: Product
       4.3.1. Introduction / Key Findings
       4.3.2. Historical Market Size (US$ Bn) Analysis, By Product, 2018 - 2022
       4.3.3. Current Market Size (US$ Bn) Analysis and Forecast, By Product, 2023 - 2031
           4.3.3.1. Diagnosis
           4.3.3.2. SPECT
           4.3.3.3. PET
   4.4. Market Attractiveness Analysis: Product
   4.5. Global Nuclear Medicine Market Outlook: Application
       4.5.1. Introduction / Key Findings
       4.5.2. Historical Market Size (US$ Bn) Analysis, By Application, 2018 - 2022
       4.5.3. Current Market Size (US$ Bn) Analysis and Forecast, By Application, 2023 - 2031
           4.5.3.1. Urology
           4.5.3.2. Cardiology
           4.5.3.3. Neurology
   4.6. Market Attractiveness Analysis: Application
   4.7. Global Nuclear Medicine Market Outlook: End Use
       4.7.1. Introduction / Key Findings
       4.7.2. Historical Market Size (US$ Bn) Analysis, By End Use, 2018 - 2022
       4.7.3. Current Market Size (US$ Bn) Analysis and Forecast, By End Use, 2023 - 2031
           4.7.3.1. Hospitals
           4.7.3.2. Diagnostic Centres
   4.8. Market Attractiveness Analysis: End Use

5. Global Nuclear Medicine Market Outlook: Region
   5.1. Key Highlights
   5.2. Historical Market Size (US$ Bn) Analysis, By Region, 2018 - 2022
   5.3. Current Market Size (US$ Bn) Analysis and Forecast, By Region, 2023 - 2031
       5.3.1. North America
       5.3.2. Europe
       5.3.3. East Asia
       5.3.4. South Asia and Oceania
       5.3.5. Latin America
       5.3.6. Middle East & Africa
   5.4. Market Attractiveness Analysis: Region

6. North America Nuclear Medicine Market Outlook: Historical (2018 - 2023) and Forecast (2024 - 2031)
   6.1. Key Highlights
   6.2. Historical Market Size (US$ Bn) Analysis, By Market, 2018 - 2022
       6.2.1. By Country
       6.2.2. By Product
       6.2.3. By Application
       6.2.4. By End Use
   6.3. Current Market Size (US$ Bn) Analysis and Forecast, By Country, 2023 - 2031
       6.3.1. U.S.
       6.3.2. Canada
   6.4. Current Market Size (US$ Bn) Analysis and Forecast, By Product, 2023 - 2031
       6.4.1. Diagnosis
       6.4.2. SPECT
       6.4.3. PET
   6.5. Current Market Size (US$ Bn) Analysis and Forecast, By Application, 2023 - 2031
       6.5.1. Urology
       6.5.2. Cardiology
       6.5.3. Neurology
   6.6. Current Market Size (US$ Bn) Analysis and Forecast, By End Use, 2023 - 2031
       6.6.1. Hospitals
       6.6.2. Diagnostic Centres
   6.7. Market Attractiveness Analysis

7. Europe Nuclear Medicine Market Outlook: Historical (2018 - 2023) and Forecast (2024 - 2031)
   7.1. Key Highlights
   7.2. Historical Market Size (US$ Bn) Analysis, By Market, 2018 - 2022
       7.2.1. By Country
       7.2.2. By Product
       7.2.3. By Application
       7.2.4. By End Use
   7.3. Current Market Size (US$ Bn) Analysis and Forecast, By Country, 2023 - 2031
       7.3.1. Germany
       7.3.2. France
       7.3.3. U.K.
       7.3.4. Italy
       7.3.5. Spain
       7.3.6. Russia
       7.3.7. Türkiye
       7.3.8. Rest of Europe
   7.4. Current Market Size (US$ Bn) Analysis and Forecast, By Product, 2023 - 2031
       7.4.1. Diagnosis
       7.4.2. SPECT
       7.4.3. PET
   7.5. Current Market Size (US$ Bn) Analysis and Forecast, By Application, 2023 - 2031
       7.5.1. Urology
       7.5.2. Cardiology
       7.5.3. Neurology
   7.6. Current Market Size (US$ Bn) Analysis and Forecast, By End Use, 2023 - 2031
       7.6.1. Hospitals
       7.6.2. Diagnostic Centres
   7.7. Market Attractiveness Analysis

8. East Asia Nuclear Medicine Market Outlook: Historical (2018 - 2023) and Forecast (2024 - 2031)
   8.1. Key Highlights
   8.2. Historical Market Size (US$ Bn) Analysis, By Market, 2018 - 2022
       8.2.1. By Country
       8.2.2. By Product
       8.2.3. By Application
       8.2.4. By End Use
   8.3. Current Market Size (US$ Bn) Analysis and Forecast, By Country, 2023 - 2031
       8.3.1. China
       8.3.2. Japan
       8.3.3. South Korea
   8.4. Current Market Size (US$ Bn) Analysis and Forecast, By Product, 2023 - 2031
       8.4.1. Diagnosis
       8.4.2. SPECT
       8.4.3. PET
   8.5. Current Market Size (US$ Bn) Analysis and Forecast, By Application, 2023 - 2031
       8.5.1. Urology
       8.5.2. Cardiology
       8.5.3. Neurology
   8.6. Current Market Size (US$ Bn) Analysis and Forecast, By End Use, 2023 - 2031
       8.6.1. Hospitals
       8.6.2. Diagnostic Centres
   8.7. Market Attractiveness Analysis

9. South Asia & Oceania Nuclear Medicine Market Outlook: Historical (2018 - 2023) and Forecast (2024 - 2031)
   9.1. Key Highlights
   9.2. Historical Market Size (US$ Bn) Analysis, By Market, 2018 - 2022
       9.2.1. By Country
       9.2.2. By Product
       9.2.3. By Application
       9.2.4. By End Use
   9.3. Current Market Size (US$ Bn) Analysis and Forecast, By Country, 2023 - 2031
       9.3.1. India
       9.3.2. Southeast Asia
       9.3.3. ANZ
       9.3.4. Rest of South Asia & Oceania
   9.4. Current Market Size (US$ Bn) Analysis and Forecast, By Product, 2023 - 2031
       9.4.1. Diagnosis
       9.4.2. SPECT
       9.4.3. PET
   9.5. Current Market Size (US$ Bn) Analysis and Forecast, By Application, 2023 - 2031
       9.5.1. Urology
       9.5.2. Cardiology
       9.5.3. Neurology
   9.6. Current Market Size (US$ Bn) Analysis and Forecast, By End Use, 2023 - 2031
       9.6.1. Hospitals
       9.6.2. Diagnostic Centres
   9.7. Market Attractiveness Analysis

10. Latin America Nuclear Medicine Market Outlook: Historical (2018 - 2023) and Forecast (2024 - 2031)
   10.1. Key Highlights
   10.2. Historical Market Size (US$ Bn) Analysis, By Market, 2018 - 2022
       10.2.1. By Country
       10.2.2. By Product
       10.2.3. By Application
       10.2.4. By End Use
   10.3. Current Market Size (US$ Bn) Analysis and Forecast, By Country, 2023 - 2031
       10.3.1. Brazil
       10.3.2. Mexico
       10.3.3. Rest of Latin America
   10.4. Current Market Size (US$ Bn) Analysis and Forecast, By Product, 2023 - 2031
       10.4.1. Diagnosis
       10.4.2. SPECT
       10.4.3. PET
   10.5. Current Market Size (US$ Bn) Analysis and Forecast, By Application, 2023 - 2031
       10.5.1. Urology
       10.5.2. Cardiology
       10.5.3. Neurology
   10.6. Current Market Size (US$ Bn) Analysis and Forecast, By End Use, 2023 - 2031
       10.6.1. Hospitals
       10.6.2. Diagnostic Centres
   10.7. Market Attractiveness Analysis

11. Middle East & Africa Nuclear Medicine Market Outlook: Historical (2018 - 2023) and Forecast (2024 - 2031)
   11.1. Key Highlights
   11.2. Historical Market Size (US$ Bn) Analysis, By Market, 2018 - 2022
       11.2.1. By Country
       11.2.2. By Product
       11.2.3. By Application
       11.2.4. By End Use
   11.3. Current Market Size (US$ Bn) Analysis and Forecast, By Country, 2023 - 2031
       11.3.1. GCC Countries
       11.3.2. Egypt
       11.3.3. South Africa
       11.3.4. Northern Africa
       11.3.5. Rest of Middle East & Africa
   11.4. Current Market Size (US$ Bn) Analysis and Forecast, By Product, 2023 - 2031
       11.4.1. Diagnosis
       11.4.2. SPECT
       11.4.3. PET
   11.5. Current Market Size (US$ Bn) Analysis and Forecast, By Application, 2023 - 2031
       11.5.1. Urology
       11.5.2. Cardiology
       11.5.3. Neurology
   11.6. Current Market Size (US$ Bn) Analysis and Forecast, By End Use, 2023 - 2031
       11.6.1. Hospitals
       11.6.2. Diagnostic Centres
   11.7. Market Attractiveness Analysis

12. Competition Landscape
   12.1. Market Share Analysis, 2023
   12.2. Market Structure
       12.2.1. Competition Intensity Mapping By Market
       12.2.2. Competition Dashboard
   12.3. Company Profiles (Details - Overview, Financials, Strategy, Recent Developments)
       12.3.1. GE Healthcare
           12.3.1.1. Overview
           12.3.1.2. Segments and Products
           12.3.1.3. Key Financials
           12.3.1.4. Market Developments
           12.3.1.5. Market Strategy
       12.3.2. Jubilant Life Sciences Ltd
       12.3.3. Nordion (Canada), Inc.
       12.3.4. Bracco Imaging S.P.A
       12.3.5. The institute for radioelements (IRE)
       12.3.6. NTP Radioisotopes SOC Ltd.
       12.3.7. The Australian Nuclear Science and Technology Organization
       12.3.8. Eczac?ba??-Monrol
       12.3.9. Lantheus Medical Imaging, Inc
       12.3.10. Eckert & Ziegler
       12.3.11. Mallinckrodt
       12.3.12. Cardinal Health